{"id":505,"date":"2025-01-09T15:15:00","date_gmt":"2025-01-09T15:15:00","guid":{"rendered":"https:\/\/www.snijderlab.org\/news\/?p=505"},"modified":"2025-12-09T20:54:31","modified_gmt":"2025-12-09T20:54:31","slug":"graph-therapeutics-launches","status":"publish","type":"post","link":"https:\/\/www.snijderlab.org\/news\/2025\/01\/09\/graph-therapeutics-launches\/","title":{"rendered":"\ud83d\ude80Graph Therapeutics"},"content":{"rendered":"\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\">\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image.png\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"443\" data-id=\"506\" src=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1024x443.png\" alt=\"\" class=\"wp-image-506\" srcset=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1024x443.png 1024w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-300x130.png 300w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-768x332.png 768w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image.png 1178w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n<\/figure>\n\n\n\n<p><a href=\"https:\/\/emojipedia.org\/rocket\"><\/a><a href=\"https:\/\/graphtx.com\/\" data-type=\"link\" data-id=\"https:\/\/graphtx.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Graph Therapeutics<\/a> (Graph Tx) raises a 3.1M euro pre-seed round to improve improve the lives of patients with immune-mediated diseases through Al-driven precision medicine.<\/p>\n\n\n\n<p>Graph Tx is based on the veteran techbio team that previously pioneered AI-driven precision oncology in Allcyte, which was acquired by Exscientia for 60M USD. The team now reunites to tackle the critical and complex challenges of inflammatory and immunological diseases. <\/p>\n\n\n\n<p>Graph uses perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies &amp; biomarkers for immune-driven diseases.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1-scaled.png\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"327\" src=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1-1024x327.png\" alt=\"\" class=\"wp-image-507\" srcset=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1-1024x327.png 1024w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1-300x96.png 300w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1-768x245.png 768w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1-1536x490.png 1536w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2025\/09\/image-1-2048x653.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Graph Therapeutics (Graph Tx) raises a 3.1M euro pre-seed round to improve improve the lives of patients with immune-mediated diseases through Al-driven precision medicine. Graph Tx is based on the veteran techbio team that previously pioneered AI-driven precision oncology in Allcyte, which was acquired by Exscientia for 60M USD. The team now reunites to tackle&hellip; <a class=\"more-link\" href=\"https:\/\/www.snijderlab.org\/news\/2025\/01\/09\/graph-therapeutics-launches\/\">Continue reading <span class=\"screen-reader-text\">\ud83d\ude80Graph Therapeutics<\/span> <span class=\"meta-nav\" aria-hidden=\"true\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,1],"tags":[],"class_list":["post-505","post","type-post","status-publish","format-standard","hentry","category-company","category-news"],"_links":{"self":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/comments?post=505"}],"version-history":[{"count":1,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/505\/revisions"}],"predecessor-version":[{"id":508,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/505\/revisions\/508"}],"wp:attachment":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/media?parent=505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/categories?post=505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/tags?post=505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}